Novo Nordisk A/S News Headlines

NVO 
$45.88
*  
0.03
0.07%
Get NVO Alerts
*Delayed - data as of Jul. 28, 2014 9:33 ET  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

GSK, Genmab Seek Arzerra EU Approval - Analyst Blog
10/7/2013 5:31:01 PM - Zacks.com

Eli Lily to Cut Costs, Shares Down - Analyst Blog
10/4/2013 12:50:01 PM - Zacks.com

NVO's Diabetes Portfolio Update - Analyst Blog
10/2/2013 3:47:38 PM - Zacks.com

Sanofi's Diabetes Portfolio Update - Analyst Blog
10/2/2013 3:28:01 PM - Zacks.com

Label Expansion for Roche's Perjeta - Analyst Blog
10/2/2013 1:50:08 PM - Zacks.com

Update on AstraZeneca's Onglyza - Analyst Blog
10/2/2013 10:46:01 AM - Zacks.com

Glaxo to Divest Arixtra and Fraxiparine - Analyst Blog
10/1/2013 11:42:20 AM - Zacks.com

Data on Novartis' Lucentis - Analyst Blog
9/30/2013 3:15:01 PM - Zacks.com

AstraZeneca Vaccine Update - Analyst Blog
9/27/2013 5:33:58 PM - Zacks.com

Lilly Down on Mixed Pipeline Data - Analyst Blog
9/27/2013 11:30:01 AM - Zacks.com

CV Study Update on NVO's Victoza - Analyst Blog
9/26/2013 5:30:01 PM - Zacks.com

Allergan Inks Deal with Medytox - Analyst Blog
9/26/2013 11:30:01 AM - Zacks.com

More Data on Novo Nordisk's Tresiba - Analyst Blog
9/25/2013 5:10:01 PM - Zacks.com

Kelly Close: State Of Diabetes Treatment, Companies In The Sector And Challenges Patients Face
9/24/2013 6:51:00 PM - Seeking Alpha

Update on Glaxo's Contracts - Analyst Blog
9/24/2013 6:15:01 PM - Zacks.com

AstraZeneca's Late-Stage Pipeline Update - Analyst Blog
9/24/2013 12:17:59 PM - Zacks.com

Regulatory Setback for Merck - Analyst Blog
9/24/2013 11:18:07 AM - Zacks.com

Novo Nordisk Advertising Weight Loss - A Future Peak At Arena Or Vivus?
9/24/2013 3:14:00 AM - Seeking Alpha

AbbVie-Ablynx Ink Deal - Analyst Blog
9/23/2013 6:53:02 PM - Zacks.com

Positive CHMP Opinion for NVO Candidate - Analyst Blog
9/23/2013 5:53:35 PM - Zacks.com

Sanofi Re-Launches Rolaids in U.S. - Analyst Blog
9/20/2013 10:36:29 AM - Zacks.com

Is Biodel A Buy Or Sell?
9/19/2013 4:40:00 PM - Seeking Alpha

Good News Flows in at Glaxo - Analyst Blog
9/19/2013 12:10:01 PM - Zacks.com

CE Mark for Abbott Product - Analyst Blog
9/18/2013 7:05:01 PM - Zacks.com

Sanofi's Lemtrada Gets EU Approval - Analyst Blog
9/17/2013 4:59:05 PM - Zacks.com